|

EVOLVING AZIMUTH IN MUSA CONTEXT

RECRUITINGN/ASponsored by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Actively Recruiting
PhaseN/A
SponsorFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Started2024-10-02
Est. completion2025-06-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07022067

Summary

Non-pharmacological, randomized, nonprofit medical device intervention. The study aims to identify the positive impacts (co-creation), and negative impacts (co-destruction), resulting from the use of telemedicine, and, in particular, the telemonitoring service for patients with heart failure

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Have been diagnosed with chronic CS according to the ESC guidelines;
* Over 18 years of age;
* Patients admitted to hospital or with access to first aid within the last year;
* Smartphome that meets the digital requirements (ie Android or iOS able to download and use the application);
* Wi-Fi or 3G coverage at home;
* Ability to give written informed consent.

Exclusion Criteria:

* Severe psychiatric disorder
* Inability to use portable technologies
* Patients unable to use the equipment provided
* Patients who deny consent to study participation

Conditions5

Blood PressureHeart DiseaseHeart FailureTelemonitoringWeight Change

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.